| Released | Contributor | Author | Title | Pages | Price |
|---|
| Jun 17, 2013 | New Constructs, LLC | N/A | CUR: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Jun 17, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - NEURALSTEM, INCORPORATION. (CUR-A) | 11 | $25 | | Jun 17, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | Jun 14, 2013 | Pechala's Reports | Frantisek Pechala | NEURALSTEM INC (CUR) 12-months forecast | 1 | $15 | | Jun 14, 2013 | Reuters Investment Profile | N/A | Neuralstem Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ALSE , CVM , CHTP , CYCC , CUR , OXBT -- DRUGS | 3 | $34.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: NEURALSTEM -- CUR | 1 | $11.50 | | Jun 12, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for CUR | 11 | $126.50 | | Jun 12, 2013 | ValuEngine, Inc. | N/A | ValuEngine - Toronto Quantitative Stock Report for CUR | 11 | $126.50 | | Jun 8, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Neuralstem, Incorporation. | 39 | $448.50 |
|
View All Reports for CUR ... |
|
|
0.03(2.11%) 4:00PM EDT